237 related articles for article (PubMed ID: 9701674)
21. Effects of inflammation on copper antioxidant enzyme levels.
DiSilvestro RA
Adv Exp Med Biol; 1989; 258():253-8. PubMed ID: 2560608
[TBL] [Abstract][Full Text] [Related]
22. Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives.
Serra JA; Famulari AL; Kohan S; Marschoff ER; Dominguez RO; de Lustig ES
J Neurol Sci; 1994 Apr; 122(2):179-88. PubMed ID: 8021702
[TBL] [Abstract][Full Text] [Related]
23. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals.
Goldstein IM; Kaplan HB; Edelson HS; Weissmann G
Ann N Y Acad Sci; 1982; 389():368-79. PubMed ID: 6284006
[TBL] [Abstract][Full Text] [Related]
24. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
[TBL] [Abstract][Full Text] [Related]
25. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
Squitti R
J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
[TBL] [Abstract][Full Text] [Related]
26. [Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)].
Johannesson T; Kristinsson J; Torsdottir G; Snaedal J
Laeknabladid; 2012 Oct; 98(10):531-7. PubMed ID: 23043066
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity.
López N; Tormo C; De Blas I; Llinares I; Alom J
J Alzheimers Dis; 2013; 33(3):823-9. PubMed ID: 23076075
[TBL] [Abstract][Full Text] [Related]
28. Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.
Pal A; Kumar A; Prasad R
Biometals; 2014 Feb; 27(1):25-31. PubMed ID: 24435851
[TBL] [Abstract][Full Text] [Related]
29. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
[TBL] [Abstract][Full Text] [Related]
30. Ceruloplasmin, extracellular-superoxide dismutase, and scavenging of superoxide anion radicals.
Marklund SL
J Free Radic Biol Med; 1986; 2(4):255-60. PubMed ID: 3034998
[TBL] [Abstract][Full Text] [Related]
31. [Neurodegenerative diseases, antioxidative enzymes and copper. A review of experimental research.].
Jóhannesson T; Kristinsson J; Snædal J
Laeknabladid; 2003 Sep; 89(9):659-71. PubMed ID: 16940591
[TBL] [Abstract][Full Text] [Related]
32. Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis.
Doğan P; Soyuer U; Tanrikulu G
Br J Dermatol; 1989 Feb; 120(2):239-44. PubMed ID: 2538138
[TBL] [Abstract][Full Text] [Related]
33. Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review.
Torsdottir G; Kristinsson J; Snaedal J; Sveinbjörnsdóttir S; Gudmundsson G; Hreidarsson S; Jóhannesson T
J Neurol Sci; 2010 Dec; 299(1-2):51-4. PubMed ID: 20851426
[TBL] [Abstract][Full Text] [Related]
34. Red cell superoxide dismutase activity as an index of human copper nutrition.
Uauy R; Castillo-Duran C; Fisberg M; Fernandez N; Valenzuela A
J Nutr; 1985 Dec; 115(12):1650-5. PubMed ID: 3934352
[TBL] [Abstract][Full Text] [Related]
35. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
Squitti R; Siotto M; Cassetta E; El Idrissi IG; Colabufo NA
Clin Chem Lab Med; 2017 Aug; 55(9):1360-1367. PubMed ID: 28076308
[TBL] [Abstract][Full Text] [Related]
36. Blood copper concentrations and cuproenzyme activities in a colony of cats.
Fascetti AJ; Rogers QR; Morris JG
Vet Clin Pathol; 2002; 31(4):183-8. PubMed ID: 12447780
[TBL] [Abstract][Full Text] [Related]
37. Effect of long-term penicillamine therapy on erythrocyte CuZn superoxide dismutase activity.
Marklund SL; Ek B; Steen L
Scand J Clin Lab Invest; 1984 Feb; 44(1):13-7. PubMed ID: 6701446
[TBL] [Abstract][Full Text] [Related]
38. Alterations of redox-status during psoriasis.
Matoshvili M; Katsitadze A; Sanikidze T; Tophuria D; Richetta A; D'Epiro S
Georgian Med News; 2014; (232-233):60-4. PubMed ID: 25214274
[TBL] [Abstract][Full Text] [Related]
39. Copper, zinc and superoxide dismutase activities in premature infants: a review.
Airede AK
East Afr Med J; 1993 Jul; 70(7):441-4. PubMed ID: 8293704
[TBL] [Abstract][Full Text] [Related]
40. Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free-living rheumatoid arthritis patients.
DiSilvestro RA; Marten J; Skehan M
J Am Coll Nutr; 1992 Apr; 11(2):177-80. PubMed ID: 1578095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
